Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Collplant Biotechnologies stock

Learn how to easily invest in Collplant Biotechnologies stock.

Collplant Biotechnologies Ltd is a biotechnology business based in the US. Collplant Biotechnologies shares (CLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Collplant Biotechnologies employs 66 staff and has a trailing 12-month revenue of around $582,000.

How to buy shares in Collplant Biotechnologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CLGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Collplant Biotechnologies stock price (NASDAQ: CLGN)

Use our graph to track the performance of CLGN stocks over time.

Collplant Biotechnologies shares at a glance

Information last updated 2022-09-26.
Latest market close$6.30
52-week range$6.51 - $23.00
50-day moving average $8.22
200-day moving average $9.95
Wall St. target price$17.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.30

Buy Collplant Biotechnologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Collplant Biotechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collplant Biotechnologies price performance over time

Historical closes compared with the close of $6.3 from 2022-09-27

1 week (2022-09-21) -21.64%
1 month (2022-08-26) -21.25%
3 months (2022-06-28) -21.40%
6 months (2022-03-28) -47.06%
1 year (2021-09-28) -63.16%
2 years (2020-09-28) -24.01%
3 years (2019-09-26) 57.11%
5 years (2017-09-24) N/A

Collplant Biotechnologies financials

Revenue TTM $582,000
Gross profit TTM $13.6 million
Return on assets TTM -18.67%
Return on equity TTM -33.72%
Profit margin 0%
Book value $3.56
Market capitalisation $78.2 million

TTM: trailing 12 months

Collplant Biotechnologies share dividends

We're not expecting Collplant Biotechnologies to pay a dividend over the next 12 months.

Have Collplant Biotechnologies's shares ever split?

Collplant Biotechnologies's shares were split on a 2:3 basis on 20 November 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Collplant Biotechnologies shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for Collplant Biotechnologies shares which in turn could have impacted Collplant Biotechnologies's share price.

Collplant Biotechnologies share price volatility

Over the last 12 months, Collplant Biotechnologies's shares have ranged in value from as little as $6.51 up to $23. A popular way to gauge a stock's volatility is its "beta".

CLGN.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collplant Biotechnologies's is 1.0979. This would suggest that Collplant Biotechnologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Collplant Biotechnologies overview

CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd.

Frequently asked questions

What percentage of Collplant Biotechnologies is owned by insiders or institutions?
Currently 10.16% of Collplant Biotechnologies shares are held by insiders and 12.234% by institutions.
How many people work for Collplant Biotechnologies?
Latest data suggests 66 work at Collplant Biotechnologies.
When does the fiscal year end for Collplant Biotechnologies?
Collplant Biotechnologies's fiscal year ends in December.
Where is Collplant Biotechnologies based?
Collplant Biotechnologies's address is: Weizmann Science Park, Rehovot, Israel, 7670104
What is Collplant Biotechnologies's ISIN number?
Collplant Biotechnologies's international securities identification number is: IL0004960188
What is Collplant Biotechnologies's CUSIP number?
Collplant Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 19516Q208

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site